Shuming Chen

Research Associate

20122017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Shuming Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Melanoma Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Safety Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Regulator Genes Medicine & Life Sciences
Granulocyte-Macrophage Colony-Stimulating Factor Medicine & Life Sciences
Human Herpesvirus 4 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2017

Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: Implications for immunotherapy

Duffield, A. S., Ascierto, M. L., Anders, R. A., Taube, J. M., Meeker, A. K., Chen, S., McMiller, T. L., Phillips, N. A., Xu, H., Ogurtsova, A., Berger, A. E., Pardoll, D. M., Topalian, S. L. & Ambinder, R. F., Jul 25 2017, In : Blood Advances. 1, 17, p. 1324-1334 11 p.

Research output: Contribution to journalArticle

Open Access
Human Herpesvirus 4
Hodgkin Disease
Immunotherapy
Interleukin-23
Interleukin-17

Differential expression of immune-regulatory genes associated with PD-L1 display in melanoma: Implications for PD-1 pathway blockade

Taube, J. M., Young, G. D., McMiller, T. L., Chen, S., Salas, J. T., Pritchard, T. S., Xu, H., Meeker, A. K., Fan, J., Cheadle, C., Berger, A. E., Pardoll, A. M. & Topalian, S., Sep 1 2015, In : Clinical Cancer Research. 21, 17, p. 3969-3976 8 p.

Research output: Contribution to journalArticle

Regulator Genes
Melanoma
Antigen Presentation
Immunosuppression
Interleukin-10

PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation

Rodic, N., Anders, R. A., Eshleman, J., Lin, M-T., Xu, H., Kim, J. H., Beierl, K., Chen, S., Luber, B. S., Wang, H., LTopalian, S., Pardoll, A. M. & Taube, J. M., Feb 1 2015, In : Cancer immunology research. 3, 2, p. 110-115 6 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Melanoma
Mutation
Melanocytes
Cell Line

Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting

Lipson, E., Sharfman, W., Chen, S., McMiller, T. L., Pritchard, T. S., Salas, J. T., Sartorius-Mergenthaler, S., Freed, I., Ravi, S., Wang, H., Luber, B., Davis Sproul, J., Taube, J. M., Pardoll, A. M. & Topalian, S., Jul 5 2015, In : Journal of Translational Medicine. 13, 1, 214.

Research output: Contribution to journalArticle

Granulocyte-Macrophage Colony-Stimulating Factor
Melanoma
Vaccines
Safety
Biopsy

Structure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicity

Chen, S., Li, Y., Depontieu, F. R., McMiller, T. L., Michelle English, A., Shabanowitz, J., Kos, F., Sidney, J., Sette, A., Rosenberg, S. A., Hunt, D. F., Mariuzza, R. A. & Topalian, S., Nov 15 2013, In : Journal of Immunology. 191, 10, p. 5097-5106 10 p.

Research output: Contribution to journalArticle

Ligands
Peptides
HLA-DR4 Antigen
Melanoma
T-Lymphocytes